CARL Carlsmed Inc

Price (delayed)

$11.17

Market cap

$303.66M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.16

Enterprise value

$247.79M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 22

We are a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. ...

Highlights
The quick ratio has soared by 82% YoY and by 33% QoQ
Carlsmed's gross profit has soared by 78% YoY and by 13% from the previous quarter
Carlsmed's net income has decreased by 33% YoY and by 10% QoQ
The equity has declined by 7% since the previous quarter

Key stats

What are the main financial stats of CARL

CARL stock price

How has the Carlsmed stock price performed over time
Intraday
9.51%
1 week
-5.42%
1 month
22.88%
1 year
N/A
YTD
-9.55%
QTD
23.43%

Financial performance

How have Carlsmed's revenue and profit performed over time
Revenue
$56.44M
Gross profit
$42.83M
Operating income
-$34.13M
Net income
-$32.6M
Gross margin
75.9%
Net margin
-57.8%
Carlsmed's gross profit has soared by 78% YoY and by 13% from the previous quarter
The revenue has soared by 75% YoY and by 12% from the previous quarter
Carlsmed's operating income has decreased by 39% YoY and by 12% from the previous quarter
Carlsmed's net income has decreased by 33% YoY and by 10% QoQ

Price vs fundamentals

How does CARL's price correlate with its fundamentals

Growth

What is Carlsmed's growth rate over time

Valuation

What is Carlsmed stock price valuation
P/E
N/A
P/B
3.24
P/S
5.31
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.39
The EPS has soared by 65% year-on-year
The equity has declined by 7% since the previous quarter
The revenue has soared by 75% YoY and by 12% from the previous quarter

Efficiency

How efficient is Carlsmed business performance
Carlsmed's ROE has soared by 77% from the previous quarter
The ROA has increased by 33% YoY and by 7% QoQ
The ROS is up by 23% year-on-year
CARL's ROIC is up by 19% year-on-year and by 11% since the previous quarter

Dividends

What is CARL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CARL.

Financial health

How did Carlsmed financials performed over time
Carlsmed's total assets has soared by 105% YoY but it has decreased by 9% from the previous quarter
The current ratio has surged by 83% year-on-year and by 34% since the previous quarter
The debt is 81% smaller than the equity
The company's debt to equity has surged by 186% YoY and by 6% QoQ
The equity has declined by 7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.